Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scrip Team

Latest From Scrip Team

Coronavirus Update: Moderna Donates More Doses, Booster Shot Shows Efficacy

Novavax said it would start shipping supplies of its vaccine to Europe starting in late 2021, while Vaxart delayed the start of its Phase II study due to issues with Emergent BioSolutions. Meanwhile, Roche India received an EUA for Regeneron's antibody cocktail

Coronavirus COVID-19 Companies

Coronavirus Update: Gilead And Zydus Cadila Expand Drugs Available In India

Gilead outlines efforts to expand availability of remdesivir in India while offers for supplies from Russia, Uzbekistan are also on the table. Zydus Cadila has received accelerated approval in India for pegylated interferon alpha-2b in moderate COVID-19 infection in adults.

Commercial Coronavirus COVID-19

Executives On The Move: New Chief Financial Officer Joins Genfit, BioVie Gets New CEO

Seneca shakes up leadership team with new CEO and chief financial officer, along with a board reshuffle.

Appointments BioPharmaceutical

Coronavirus Update: Inovio Looks Outside US To Continue Vaccine Development

Inovio looks to countries outside the US to continue late-stage development of its vaccine, while a South Korean firm strikes a supply deal with Indonesia and Japan approves a new drug for COVID-19. 

Coronavirus COVID-19 BioPharmaceutical

Executives On The Move: New CFOs at Allakos, Immunome, And Teligent; New CEO Joins Peptonic Medical

Reshuffle among regulatory functions at Eledon Pharmaceuticals, and a slew of new directors at Goldfinch Bio.

Appointments BioPharmaceutical

Coronavirus Update: Bharat's Vaccine Looks Good In New Analysis

New Phase III data show efficacy ranging up to 100% for Bharat Biotech's inactivated vaccine, while also in India, Serum Institute sets new prices for its vaccine. Meanwhile, Russia's RDIF strikes new production deals in South Korea. 

Coronavirus COVID-19 Vaccines
See All
UsernamePublicRestriction

Register